Milani Erase Base Blemish Control Primer Salicylic Acid Cream
NDC Package 71435-0005-0
Package Information
Milani Erase Base Blemish Control Primer Salicylic Acid (salicylic acid) cream is • Clean the skin thoroughly before applying this product • Cover the entire affected area with a thin layer one to three times daily • Drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor • If bothersome dryness or peeling occurs, reduce application to once a day or every other day. This formulation utilizes a cream delivery system. Marketed by New Milani Group, Llc, this product is identified by NDC 71435-0005 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 317152 - salicylic acid 2 % Topical Cream
- RxCUI: 317152 - salicylic acid 20 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71435 - New Milani Group, Llc
- 71435-0005 - Milani Erase Base Blemish Control Primer Salicylic Acid
- 71435-0005-0 - 30 mL in 1 TUBE
- 71435-0005 - Milani Erase Base Blemish Control Primer Salicylic Acid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71435-0005-0 identifies a specific commercial package of 30 ml in 1 tube of Milani Erase Base Blemish Control Primer Salicylic Acid, a human over the counter drug labeled by New Milani Group, Llc. This cream is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by New Milani Group, Llc on June 01, 2022. The current certification is valid through December 31, 2026.
How is this New Milani Group, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71435000500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.